Filter by
Filters
Clear filters

Publication date

2019 year - 2020 year

Author

Price

42.00 zł - 105.00 zł

Delivery time

2 days - 2 days

Publication form

Language

Publisher

Fact facts: Asthma for...

Fact facts: Asthma for Patients and Information

Author: John Harrington
Publishing date: 2020
Asthma is a long-term condition that reduces the amount of air flowing in and out of the lungs. Whether your symptoms are mild, difficult-to-control or severe, it is important to be in control of your asthma. The information in this booklet is designed to help you and your family better understand the condition, what triggers it and how to treat it. It includes clear instructions for good inhaler technique and emphasizes the importance of having an Asthma Action Plan in place so that you know: ; when and how often to take your treatment; how to tell if your symptoms are getting worse; what to do when your symptoms get worse. With simple clear illustrations, explanation of medical terms and space to write down the questions you want to ask your doctor or nurse, this
42.00 zł
Fast Facts: Biosimilars in...

Fast Facts: Biosimilars in Hematology and Oncology

Author: Ali McBride
Paul Cornes
Publishing date: 2020
Biologics have revolutionized - and are revolutionizing - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Fast Facts: Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients. Contents: - Biologics and the need for
105.00 zł
Fast Facts:...

Fast Facts: Myeloproliferative Neoplasms

Author: Claire Harrison
Ruben Mesa
Publishing date: 2019
Presentation of the myeloproliferative neoplasms (MPNs) varies widely, and correct diagnosis and management can be challenging, and is becoming more complex as understanding of the underlying molecular basis for these disorders emerges. Appropriate management is increasingly informed by accurate risk stratification founded on understanding of cytogenetic and molecular markers, as well as the clinical presentation. 'Fast Facts: myeloproliferative neoplasms' focuses on the three most common chronic MPNs: - Essential thrombocythemia (ET) - characterized by increased platelet count - Polycythemia vera (PV) - characterized by excessive production of red blood cells - Primary myelofibrosis - a more severe and heterogenous disorder that may overlap with ET and PV but
101.00 zł
Fast Facts: Peripheral...

Fast Facts: Peripheral T-cell Lymphoma

Author: Christopher Fox
Francine Foss
Matthew Ahearne
Publishing date: 2019
The peripheral T-cell lymphomas (PTCLs) are a heterogenous group of rare entities. Whilst cytogenetic and molecular identifiers are being identified, accurate diagnosis remains challenging, requiring careful, expert integration of the clinical and pathological findings. The treatment of PTCL is also challenging. Protocols for the different subtypes are only just beginning to emerge, hindered by the complexities of conducting trials in such uncommon and varied conditions. While first-line treatment with conventional chemotherapy is seldom curative, patients who achieve remission may be eligible for stem cell transplantation, offering the possibility of long-term disease control if not cure. Targeted biologics are also being developed as unique cytotoxic markers are
100.00 zł